Weitz & Luxenberg is no longer accepting Trasylol cases

Heart-surgery med Trasylol may increase the risk of kidney failure: Defective Drug Attorneys.

September 30, 2006
 

On Friday, the Food and Drug Administration (FDA) announced that German pharmaceutical giant Bayer A.G., had failed to alert federal drug officials that their popular heart-surgery drug Trasylol, might increase the health risks of death and stroke.

The drug company had known of those risks after learning the results of a large-scale study it conducted.

According to an article in the New York Times, Bayer scientists even attended a public meeting with the FDA in late September to discuss the drug's risks but did not mention the large-scale study conducted by the company with its very troubling results.

Another study, published in January in the New England Journal of Medicine, found that the Trasylol, which is given to patients before heart surgery, may increase the risks of kidney failure, heart attack and stroke.

If you were given Trasylol during or after surgery and suffered kidney failure, please fill out the form below for a free Trayslol lawsuit review. A representative of our firm will be in touch with you shortly.

see also:

Learn More Side Effects of Trasylol Include Kidney Failure--Lawyers Investigate
Trasylol has been found to cause kidney problems--free legal review

Trasylol FDA Alert: Trasylol and Increased Risk of Kidney Falure. Lawyers
Trasylol drug raises risk of serious side effects. Free Lawsuit Review

Trasylol FDA Alert Trasylol alert: FDA Issues Public Health Advisory. Free Legal Review
FDA issues warning on blood-clotting drug Trasylol. Get Lawsuit Info